Communities of practice
TropIKA.net Partnerships
Leishmaniasis 
Leishmania parasites are named after W.B. Leishman, who developed one of the earliest stains of Leishmania in 1901. Widespread in 22 countries in the New World and in 66 nations in the Old World, leishmaniasis is not found in South-east Asia. Human infections are found in 16 countries in Europe, including France, Italy, Greece, Malta, Spain and Portugal. Occurring in several forms, the disease is generally recognized for its cutaneous form which causes non-fatal, disfiguring lesions, although epidemics of the potentially fatal visceral form cause thousands of deaths.
Review Articles
2 Jun 2010
Do the poor benefit from infectious disease programmes?
When interventions are planned, insufficient thought is given as to whether the poorest and most vulnerable members of society will benefit, according to the findings of a new review of the evidence. The reviewers call for more research to assess which infectious disease programmes benefit the poor and to identify the mechanisms that determine “pro-poor effectiveness”.
Source: TropIKA.net Journal
Read...
| PDF
31 May 2010
Treating patients with visceral leishmaniasis in the Indian subcontinent: the evidence from clinical trials
A review of trials concludes that three drugs are of overall benefit, despite their side effects. Most research has been conducted in India; more must be done to confirm which drugs work best in Bangladesh and Nepal and to bring effective treatment to patients in all three countries.
Source: TropIKA.net Journal
Read...
| PDF
More Leishmaniasis Review Articles >
News
13 Jul 2010
Potential TB drugs to be investigated against neglected diseases
Two not-for-profit drug developers have established a partnership that will seek to find treatments for a wide variety of neglected infections, based on a series of compounds from the nitroimidazole class.
Source: Drugs for Neglected Diseases initiative (DNDi); Global Alliance for TB Drug Development
Read...
28 May 2010
Public searches now possible of database of global R&D funding
Access to data from the G-FINDER survey will help funders and product developers better understand where funding gaps lie and how their investments fit into the global picture.
Source: George Institute
Read...
Editorial Opinions
No Editorial Opinions
Research Articles
20 May 2010
New drugs still lacking for the infectious diseases of poverty
So far in the 21st century (and with the exception of malaria and AIDS), only four new products have become available for treating or preventing infections in poor communities.
Source: PLoS ONE
Read...
| PDF 
14 Apr 2010
Leishmaniasis attracts increased attention from researchers
TropIKA.net looks at some recent research publications on a much-neglected infectious disease of poverty.
Source: TropIKA.net
Read...
More Leishmaniasis Research Articles >
Reports
18 Dec 2009
Neglected disease research & development: new times, new trends
The global budget for research into the infectious diseases of poverty is little changed and AIDS continues to receive a disproportionately large share of the total. But India and Brazil are emerging as key players, particular for the more neglected diseases.
Source: George Institute
Read...
| PDF
23 Dec 2008
The World Can’t Wait: More Funding Needed for Research on Neglected Infectious Diseases
US consumer group reports on government expenditure on neglected infections and says it is not enough.
Source: Families USA
Read...
| PDF
Meeting Knowledge Hubs:
Is your organisation working against the infectious diseases of poverty?
